Skip to main content
. Author manuscript; available in PMC: 2016 Aug 1.
Published in final edited form as: Nat Rev Gastroenterol Hepatol. 2015 Jun 30;12(8):437–445. doi: 10.1038/nrgastro.2015.97

Figure 3.

Figure 3

Median viral load decays from baseline (points) and nonparametric kinetic fitting (line) caused by agents belonging to different therapeutic classes during (A) short-term monotherapy or (B) combination therapy. (A). IFN 10 or 15 MIU QD6 (black), mericitabine 1500 mg BID44 (green), sofosbuvir 400 mg QD37 (red), telaprevir 750 mg q8h35 (blue) and a single dose of daclatasvir (10 or 100 mg, purple)43. (B). IFN 10 or 15 MIU QD6 (black), sofosbuvir 400 mg QD + RBV (red)57, telaprevir 750 mg q8h + Peg-IFN35 (blue) and sofosbuvir 400 mg QD + ledipasvir 90 mg QD61 (purple).